Successful PhD defenses for Aarazo Barakzie and Lorenzo Romano
Recently Aarazo Barakzie and Lorenzo Romano successfully defended their dissertations.
At the department of Hematology we are dedicated to improving the diagnosis and treatment of patients with hematological diseases. We perform basic and translational research to generate insight into the pathobiology of hematological diseases, and translate these findings into novel treatments for our patients.
In addition, we direct a wide variety of clinical studies, closely linked to our preclinical programs. These clinical studies deal with the development of molecular diagnostics, advancement of allogeneic stem cell transplantation, circumvention of drug-resistance to chemotherapy as well as a broad range of clinical phase I to phase III trials for a variety of hematological diseases.
For more information on clinical care for patients with hematological diseases please see our clinical homepage.
News
Registration for the 9th Workshop on "Molecular aspects of normal and malignant hematopoiesis" has opened!
The 9th workshop on “Molecular aspects of hematological malignancies” will take place on 8 and 9 June, 2026 in Rotterdam. This meeting is meant to give young investigators (PhD's or Postdocs) a platform to present their most recent work. It is a perfect moment for young investigators in our field to meet and create their own network.
ASH Abstract Achievement Awards for Dimitris Kotsos and Amica Ko
PhD students Dimitris Kotsos and Amica Ko have both won ASH Abstract Achievement Awards.
Jurjen Versluis receives cheque from Mixed Choir Chapeau
During the autumn concert, the mixed choir Chapeau raised funds for scientific research at the Erasmus MC Cancer Institute into acute myeloid leukemia for the group of Dr Jurjen Versluis.
LSBR awards € 1.6 Million Anniversary Grant to HemoTwin-BD Consortium, including Ruben Bierings and Ferdows Atiq
The Landsteiner Foundation for Blood Transfusion Research (LSBR) has awarded the LSBR Anniversary Grant of € 1.6 million to the HemoTwin-BD consortium. HemoTwin-BD is a nation-wide, multidisciplinary research program aimed at understanding heterogeneity in the laboratory and bleeding phenotype of patients with bleeding disorders. Dr Ferdows Atiq and Dr Ruben Bierings, from the department of Hematology at Erasmus MC, are key members of the collaboration, overseeing the research on von Willebrand disease and von Willebrand Factor cell biology, respectively.
5 years of Erasmus virtual Hematology lectures!
We are excited to announce our new digital lecture series. This series starts on 9 February and marks 5 years of Erasmus virtual Hematology lectures!
Events
2026 Spring lecture series
2026 Molecular Workshop
The Spring digital lecture series starts on February 9th.
Everyone is invited to attend. Registration not necessary and attendance is free of charge.
If want to be updated on our lecture series and receive the links, subscribe to our newsletter here.
The 9th workshop on “Molecular aspects of hematological malignancies” will take place on 8 and 9 June, 2026 in Rotterdam. This meeting is meant to give young investigators (PhD's or Postdocs) a platform to present their most recent work. It is a perfect moment for young investigators in our field to meet and create their own network.
You can find more information on the workshop website.